iSpeciman is a technology-driven company engaged in life science research and development via a single global marketplace platform that connects researchers to subjects, specimens, and associated data. Co.'s technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions. In addition to providing the technology platform to connect researchers and healthcare providers, Co. handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The ISPC stock yearly return is shown above.
The yearly return on the ISPC stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ISPC annual return calculation with any dividends reinvested as applicable (on ex-dates).
|